Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georg C Hutterer

Showing results (31-40 of 78) with videos related to

Pageof 8
Sort By:
International Journal of Molecular Sciences|September 9, 2016
Current Status of Long Non-Coding RNAs in Human Breast CancerStefanie Cerk, Daniela Schwarzenbacher, Jan Basri Adiprasito, et al.
Histopathology|October 2, 2012
Comparison of the 2002 and 2010 TNM classification systems regarding outcome prediction in clear cell and papillary renal cell carcinomaMartin Pichler, Georg C Hutterer, Thomas F Chromecki, et al.
Urologic Oncology|December 10, 2017
p53-expression in patients with renal cell carcinoma correlates with a higher probability of disease progression and increased cancer-specific mortality after surgery but does not enhance the predictive accuracy of robust outcome modelsLaura Morshaeuser, Matthias May, Maximilian Burger, et al.
International Journal of Molecular Sciences|April 20, 2016
Current Insights into Long Non-Coding RNAs in Renal Cell CarcinomaMaximilian Seles, Georg C Hutterer, Tobias Kiesslich, et al.
The Journal of Urology|February 12, 2014
Validation of the preoperative plasma fibrinogen level as a prognostic factor in a European cohort of patients with localized upper tract urothelial carcinomaMartin Pichler, Orietta Dalpiaz, Georg C Ehrlich, et al.
Journal of Clinical Pathology|February 10, 2015
Pretreatment lymphocyte-monocyte ratio as a potential prognostic factor in a cohort of patients with upper tract urothelial carcinomaGeorg C Hutterer, N Sobolev, Georg C Ehrlich, et al.
Urology|December 3, 2024
Intermediate- and Long-term Results After Adjustable Transobturator Male System ImplantationSamra Jasarevic, Doroteja Jankovic, Georg C Hutterer, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|December 5, 2008
Effect of body mass index on prostate-specific antigen and percentage free prostate-specific antigen: results from a prostate cancer screening cohort of 1490 menUmberto Capitanio, Paul Perrotte, Georg C Hutterer, et al.
Journal of Clinical Pathology|April 12, 2015
Preoperative serum-gamma-glutamyltransferase (GGT) does not represent an independent prognostic factor in a European cohort of patients with non-metastatic renal cell carcinomaOrietta Dalpiaz, Martin Pichler, Edvin Mrsic, et al.
Journal of Endourology|February 26, 2008
Lower urinary tract symptoms affect one-third of men in a prostate cancer screening populationJochen Walz, Nazareno Suardi, Georg C Hutterer, et al.
Pageof 8

Showing results (31-40 of 78) with videos related to

Sort By:
Pageof 8
International Journal of Molecular Sciences|September 9, 2016
Current Status of Long Non-Coding RNAs in Human Breast CancerStefanie Cerk, Daniela Schwarzenbacher, Jan Basri Adiprasito, et al.
Histopathology|October 2, 2012
Comparison of the 2002 and 2010 TNM classification systems regarding outcome prediction in clear cell and papillary renal cell carcinomaMartin Pichler, Georg C Hutterer, Thomas F Chromecki, et al.
Urologic Oncology|December 10, 2017
p53-expression in patients with renal cell carcinoma correlates with a higher probability of disease progression and increased cancer-specific mortality after surgery but does not enhance the predictive accuracy of robust outcome modelsLaura Morshaeuser, Matthias May, Maximilian Burger, et al.
International Journal of Molecular Sciences|April 20, 2016
Current Insights into Long Non-Coding RNAs in Renal Cell CarcinomaMaximilian Seles, Georg C Hutterer, Tobias Kiesslich, et al.
The Journal of Urology|February 12, 2014
Validation of the preoperative plasma fibrinogen level as a prognostic factor in a European cohort of patients with localized upper tract urothelial carcinomaMartin Pichler, Orietta Dalpiaz, Georg C Ehrlich, et al.
Journal of Clinical Pathology|February 10, 2015
Pretreatment lymphocyte-monocyte ratio as a potential prognostic factor in a cohort of patients with upper tract urothelial carcinomaGeorg C Hutterer, N Sobolev, Georg C Ehrlich, et al.
Urology|December 3, 2024
Intermediate- and Long-term Results After Adjustable Transobturator Male System ImplantationSamra Jasarevic, Doroteja Jankovic, Georg C Hutterer, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|December 5, 2008
Effect of body mass index on prostate-specific antigen and percentage free prostate-specific antigen: results from a prostate cancer screening cohort of 1490 menUmberto Capitanio, Paul Perrotte, Georg C Hutterer, et al.
Journal of Clinical Pathology|April 12, 2015
Preoperative serum-gamma-glutamyltransferase (GGT) does not represent an independent prognostic factor in a European cohort of patients with non-metastatic renal cell carcinomaOrietta Dalpiaz, Martin Pichler, Edvin Mrsic, et al.
Journal of Endourology|February 26, 2008
Lower urinary tract symptoms affect one-third of men in a prostate cancer screening populationJochen Walz, Nazareno Suardi, Georg C Hutterer, et al.
Pageof 8